{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19 treatment",
      "COVID-19 vaccines",
      "NeuroCOVID",
      "transcribrial route",
      "viral loads"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37698524",
  "DateCompleted": {
    "Year": "2023",
    "Month": "10",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "10",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "09",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1021/acschemneuro.3c00488"
    ],
    "Journal": {
      "ISSN": "1948-7193",
      "JournalIssue": {
        "Volume": "14",
        "Issue": "19",
        "PubDate": {
          "Year": "2023",
          "Month": "Oct",
          "Day": "04"
        }
      },
      "Title": "ACS chemical neuroscience",
      "ISOAbbreviation": "ACS Chem Neurosci"
    },
    "ArticleTitle": "Intranasal Route: A Nasocerebral Approach against SARS-CoV-2 in NeuroCOVID.",
    "Pagination": {
      "StartPage": "3560",
      "EndPage": "3563",
      "MedlinePgn": "3560-3563"
    },
    "Abstract": {
      "AbstractText": [
        "The nasal cavity is a prime site for viral load of SARS-CoV-2 in COVID-19, as is evident from the fact that this area has been used for sample collection for the diagnosis of COVID-19. The nasal cavity has a connection with the brain across the cribriform plate which has been reported to be a route of SARS-CoV-2 to the olfactory apparatus and the brain. Targeting the SARS-CoV-2 in the nasal cavity in patients presenting with COVID-19 and long-COVID can result in the prevention and treatment of neurological deficits and therefore needs to be prioritized as a route of potential significance."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-0626-216X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Senior Researcher, Lead Scientist COVID-19 and Long-COVID, St. George's Hospital, 83043 Bad Aibling, Germany."
          }
        ],
        "LastName": "Baig",
        "ForeName": "Abdul Mannan",
        "Initials": "AM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CEO Research and Development, Health-Shield, Vedicinals-9 40764 Langenfeld, Germany."
          }
        ],
        "LastName": "Gerlach",
        "ForeName": "Joachim",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "ACS Chem Neurosci",
    "NlmUniqueID": "101525337",
    "ISSNLinking": "1948-7193"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Post-Acute COVID-19 Syndrome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Brain"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nasal Cavity"
    }
  ]
}